These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15156413)

  • 21. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
    Singhania N; Puri D; Madhu SV; Sharma SB
    QJM; 2008 Jun; 101(6):449-55. PubMed ID: 18385148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
    Gao L; Mann GE
    Cardiovasc Res; 2009 Apr; 82(1):9-20. PubMed ID: 19179352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial dysfunction in diabetic erectile dysfunction.
    Musicki B; Burnett AL
    Int J Impot Res; 2007; 19(2):129-38. PubMed ID: 16775612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of nitric oxide in insulin-dependent diabetes mellitus-related vascular complications.
    Traub O; Van Bibber R
    West J Med; 1995 May; 162(5):439-45. PubMed ID: 7785258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
    Schäfer A; Alp NJ; Cai S; Lygate CA; Neubauer S; Eigenthaler M; Bauersachs J; Channon KM
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1720-6. PubMed ID: 15242858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
    Nakagawa T; Sato W; Glushakova O; Heinig M; Clarke T; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Johnson RJ; Croker B
    J Am Soc Nephrol; 2007 Feb; 18(2):539-50. PubMed ID: 17202420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Lipoproteins, glycoxidation and diabetic angiopathy'.
    Jenkins AJ; Best JD; Klein RL; Lyons TJ
    Diabetes Metab Res Rev; 2004; 20(5):349-68. PubMed ID: 15343582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endothelial dysfunction in diabetes].
    Nishio Y
    Nihon Rinsho; 2010 May; 68(5):823-6. PubMed ID: 20446576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic angiopathy: tracking down the culprits.
    Tooke JE; Shore AC; Cohen RA; Kluft C
    J Diabetes Complications; 1996; 10(3):173-81. PubMed ID: 8807468
    [No Abstract]   [Full Text] [Related]  

  • 30. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
    Rask-Madsen C; King GL
    Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells.
    Makino N; Maeda T; Sugano M; Satoh S; Watanabe R; Abe N
    J Diabetes Complications; 2005; 19(6):347-55. PubMed ID: 16260352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
    Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
    J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A; Beckman JA; Schmidt AM; Creager MA
    Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial function and hypertension.
    Landmesser U; Drexler H
    Curr Opin Cardiol; 2007 Jul; 22(4):316-20. PubMed ID: 17556884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human endothelial cell nitric oxide synthesis by advanced glycation end-products but not glucose: relevance to diabetes.
    Xu B; Ji Y; Yao K; Cao YX; Ferro A
    Clin Sci (Lond); 2005 Nov; 109(5):439-46. PubMed ID: 16022682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The endothelial dysfunction in diabetes mellitus.
    Pănuş C; Moţa M; Vladu D; Vanghelie L; Răducanu CL
    Rom J Intern Med; 2003; 41(1):27-33. PubMed ID: 15529582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Workshop: endothelial cell dysfunction leading to diabetic nephropathy : focus on nitric oxide.
    Goligorsky MS; Chen J; Brodsky S
    Hypertension; 2001 Feb; 37(2 Pt 2):744-8. PubMed ID: 11230367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus.
    Zou MH; Cohen R; Ullrich V
    Endothelium; 2004; 11(2):89-97. PubMed ID: 15370068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity.
    Li R; Wang WQ; Zhang H; Yang X; Fan Q; Christopher TA; Lopez BL; Tao L; Goldstein BJ; Gao F; Ma XL
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1703-8. PubMed ID: 17895290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amelioration effects of berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro.
    Hao M; Li SY; Sun CK; Jingyu-Xu ; Lin Y; Liu KX; Wang L; Li CX; Zhou Q; Du JL; Li H
    Eur J Pharmacol; 2011 Mar; 654(3):320-5. PubMed ID: 21236251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.